GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Tau Medical Ltd (NAS:DRTS) » Definitions » EBITDA Margin %

DRTS (Alpha Tau Medical) EBITDA Margin % : 0.00% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alpha Tau Medical EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Alpha Tau Medical's EBITDA for the three months ended in Dec. 2024 was $-5.67 Mil. Alpha Tau Medical's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, Alpha Tau Medical's EBITDA margin for the quarter that ended in Dec. 2024 was 0.00%.


Alpha Tau Medical EBITDA Margin % Historical Data

The historical data trend for Alpha Tau Medical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Tau Medical EBITDA Margin % Chart

Alpha Tau Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial - - - - -

Alpha Tau Medical Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Alpha Tau Medical's EBITDA Margin %

For the Biotechnology subindustry, Alpha Tau Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Tau Medical's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's EBITDA Margin % falls into.



Alpha Tau Medical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Alpha Tau Medical's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-30.339/0
= %

Alpha Tau Medical's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-5.673/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Tau Medical  (NAS:DRTS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Alpha Tau Medical EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Alpha Tau Medical's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpha Tau Medical Business Description

Traded in Other Exchanges
N/A
Address
Kiryat Hamada Street 5, Jerusalem, ISR, 9777605
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.